CHEBI:76840 - EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor ChEBI ID CHEBI:76840 Definition An EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of any enzyme in the EC 1.14.99.* (miscellaneous) category. Stars This entity has been manually annotated by the ChEBI Team. ChEBI Ontology Outgoing EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor (CHEBI:76840) is a EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor (CHEBI:76741) Incoming EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor (CHEBI:35544) is a EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor (CHEBI:76840) EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor (CHEBI:131509) is a EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor (CHEBI:76840) EC 1.14.99.9 (steroid 17α-monooxygenase) inhibitor (CHEBI:68640) is a EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor (CHEBI:76840) Synonyms Sources EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitors ChEBI EC 1.14.99.* inhibitor ChEBI EC 1.14.99.* inhibitors ChEBI miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.99.*) inhibitor ChEBI miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.99.*) inhibitors ChEBI Last Modified 13 August 2021